The Preclinical CROs Market is expanding as pharmaceutical and biotechnology companies increasingly outsource research activities to specialized contract research organizations to accelerate drug discovery and development. The market size was estimated at US$ 5.52 billion in 2023 and is expected to reach US$ 11.19 billion by 2031, registering an estimated CAGR of 9.2% through 2031. Rising...